Advisornet Financial’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $307K | Sell |
7,186
-1,545
| -18% | -$83.9K | 0.01% | 529 |
|
|
2026
Q1 | $548K | Buy |
8,731
+2,858
| +49% | +$229K | 0.03% | 363 |
|
|
2025
Q4 | $560K | Buy |
5,873
+553
| +10% | +$54.2K | 0.03% | 362 |
|
|
2025
Q3 | $519K | Buy |
5,320
+203
| +4% | +$21K | 0.03% | 367 |
|
|
2025
Q2 | $550K | Buy |
5,117
+31
| +0.6% | +$3.14K | 0.04% | 348 |
|
|
2025
Q1 | $513K | Buy |
5,086
+791
| +18% | +$79.7K | 0.04% | 347 |
|
|
2024
Q4 | $384K | Sell |
4,295
-827
| -16% | -$72.8K | 0.03% | 369 |
|
|
2024
Q3 | $429K | Buy |
5,122
+1,336
| +35% | +$105K | 0.03% | 352 |
|
|
2024
Q2 | $292K | Buy |
3,786
+223
| +6% | +$16.3K | 0.03% | 406 |
|
|
2024
Q1 | $244K | Buy |
3,563
+24
| +0.7% | +$1.54K | 0.02% | 436 |
|
|
2023
Q4 | $205K | Buy |
3,539
+290
| +9% | +$15.5K | 0.02% | 464 |
|
|
2023
Q3 | $172K | Sell |
3,249
-2,575
| -44% | -$135K | 0.02% | 486 |
|
|
2023
Q2 | $315K | Sell |
5,824
-164
| -3% | -$8.57K | 0.03% | 388 |
|
|
2023
Q1 | $300K | Buy |
5,988
+465
| +8% | +$21.9K | 0.03% | 388 |
|
|
2022
Q4 | $256K | Sell |
5,523
-1,765
| -24% | -$76.4K | 0.03% | 424 |
|
|
2022
Q3 | $282K | Buy |
7,288
+282
| +4% | +$11.3K | 0.03% | 430 |
|
|
2022
Q2 | $261K | Sell |
7,006
-9,688
| -58% | -$394K | 0.03% | 442 |
|
|
2022
Q1 | $739K | Buy |
16,694
+275
| +2% | +$11.9K | 0.05% | 303 |
|
|
2021
Q4 | $697K | Sell |
16,419
-829
| -5% | -$34.8K | 0.04% | 333 |
|
|
2021
Q3 | $748K | Sell |
17,248
-41,533
| -71% | -$1.84M | 0.05% | 291 |
|
|
2021
Q2 | $2.51M | Sell |
58,781
-9,274
| -14% | -$390K | 0.17% | 128 |
|
|
2021
Q1 | $2.63M | Buy |
68,055
+7,343
| +12% | +$278K | 0.19% | 126 |
|
|
2020
Q4 | $2.18M | Buy |
60,712
+2,550
| +4% | +$91.9K | 0.18% | 125 |
|
|
2020
Q3 | $2.22M | Buy |
58,162
+597
| +1% | +$23K | 0.19% | 122 |
|
|
2020
Q2 | $2.02M | Sell |
57,565
-195
| -0.3% | -$7.02K | 0.16% | 136 |
|
|
2020
Q1 | $1.89M | Buy |
57,760
+7,717
| +15% | +$301K | 0.17% | 121 |
|
|
2019
Q4 | $2.26M | Sell |
50,043
-1,191
| -2% | -$49.8K | 0.19% | 114 |
|
|
2019
Q3 | $2.08M | Sell |
51,234
-1,247
| -2% | -$52.8K | 0.19% | 112 |
|
|
2019
Q2 | $2.26M | Sell |
52,481
-6,704
| -11% | -$258K | 0.25% | 93 |
|
|
2019
Q1 | $2.27M | Buy |
59,185
+5,386
| +10% | +$206K | 0.28% | 86 |
|
|
2018
Q4 | $1.9M | Buy |
53,799
+541
| +1% | +$19.6K | 0.26% | 89 |
|
|
2018
Q3 | $2.05M | Sell |
53,258
-1,516
| -3% | -$52.9K | 0.26% | 85 |
|
|
2018
Q2 | $1.79M | Buy |
54,774
+9,045
| +20% | +$273K | 0.24% | 85 |
|
|
2018
Q1 | $1.25M | Buy |
45,729
+6,086
| +15% | +$165K | 0.17% | 113 |
|
|
2017
Q4 | $983K | Buy |
+39,643
| New | +$1.09M | 0.15% | 130 |
|
Other funds holding BSX
Advisornet Financial's BSX Position: Q2 2026 in Review
Advisornet Financial reduced its Boston Scientific (BSX) stake by 18% in Q2 2026, selling an estimated $83.9K and leaving 7,186 shares worth $307K. The position accounts for 0.01% of the portfolio, ranked #529.
Advisornet Financial first reported a position in BSX in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.63M in Q1 2021. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Advisornet Financial held 7,186 shares of Boston Scientific worth $307K as of Q2 2026.
- Advisornet Financial sold 1,545 Boston Scientific shares in Q2 2026, an estimated $83.9K.
- Boston Scientific made up 0.01% of Advisornet Financial's portfolio in Q2 2026, its #529 holding.
- Advisornet Financial first reported a position in Boston Scientific in Q4 2017 and has held it in 35 quarters since.
- Advisornet Financial's Boston Scientific position peaked at $2.63M in Q1 2021.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.